Renal & Urology News provides news coverage of about two dozen national and international meetings annually. Some of these meetings are a lot smaller than the annual meetings of the American Society of Nephrology and American Urological Society, but that does not mean we take them less seriously from a news standpoint.
Patients with end-stage renal disease (ESRD) are at higher risk of death within the first 120 days of hemodialysis compared with 121-365 days after hemodialysis initiation, according to a report.
The phosphate binder lanthanum carbonate does not adversely affect cognitive function in hemodialysis patients compared with standard phosphate binders, according to a study published in Kidney International (2007;71:252-259).
Growth hormone therapy may safely improve lean body mass (LBM), cardiovascular risk factors, and quality of life in adult patients on maintenance hemodialysis, data suggest.
Data from a Moroccan study implicate calcium and phosphate metabolism abnormalities in the pathogenesis of heart valve calcifications in patients on hemodialysis.
Long-term use of vitamin E-coated polysulfone membrane (VECM) dialysis filters may significantly improve hemoglobin levels and reduce requirements of erythropoietin (EPO), according to an Italian study.
SAN DIEGO—No baseline transferrin saturation (TSAT), serum ferritin, or soluble transferrin receptor value predicts how hemodialysis patients with high ferritin levels will respond to IV iron therapy.
